Prioritizing rs7294 as a mirSNP contributing to warfarin dosing variability

Pharmacogenomics. 2020 Mar;21(4):257-267. doi: 10.2217/pgs-2019-0137. Epub 2020 Jan 24.

Abstract

Aim: The role of mirSNPs in the 3'UTR of VKORC1, CYP2C9 and CYP4F2 genes that could influence warfarin dose variability via a discrete miRNA-mediated mechanism remains unexplained. Methods: Genotypic data in the 1000 Genomes dataset were analyzed for pair-wise linkage disequilibrium and allelic enrichment. Results: MirSNP rs7294 in the 3'UTR of VKORC1 gene displayed varying strengths of linkage disequilibrium with rs9923231 and rs9934438 across populations, albeit consistently associated with higher warfarin dose requirements based on genome-wide association studies, meta-analysis and population-based association studies. In silico analysis predicted altered hybrid stability for the hsa-miR-133a-3p conserved binding site, providing evidence for miRNA-mediated gene regulation. Conclusion: The results support the inclusion of rs7294 as a functional variable for population-specific dosing algorithms to improve dosing accuracy.

Keywords: VKORC1; 1000 genomes; 3’UTR; MirSNP; eQTL; hybrid stability; linkage disequilibrium; miRNA; rs7294; warfarin.

MeSH terms

  • 3' Untranslated Regions / genetics
  • Alleles
  • Cytochrome P-450 CYP2C9 / genetics
  • Cytochrome P450 Family 4 / genetics
  • Gene Frequency / genetics
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Linkage Disequilibrium / genetics
  • MicroRNAs / genetics*
  • Pharmacogenetics / methods
  • Polymorphism, Single Nucleotide / genetics*
  • Vitamin K Epoxide Reductases / genetics
  • Warfarin / administration & dosage*

Substances

  • 3' Untranslated Regions
  • MicroRNAs
  • Warfarin
  • Cytochrome P-450 CYP2C9
  • Cytochrome P450 Family 4
  • Vitamin K Epoxide Reductases